Skip to main content

Peer Review reports

From: Troglitazone suppresses telomerase activity independently of PPARγ in estrogen-receptor negative breast cancer cells

Original Submission
27 Nov 2009 Submitted Original manuscript
17 Jan 2010 Reviewed Reviewer Report - Martin Fenner
21 Mar 2010 Reviewed Reviewer Report - KEFAH MOKBEL
7 May 2010 Author responded Author comments - Susan Done
Resubmission - Version 2
7 May 2010 Submitted Manuscript version 2
14 May 2010 Reviewed Reviewer Report - KEFAH MOKBEL
26 May 2010 Reviewed Reviewer Report - Martin Fenner
8 Jun 2010 Author responded Author comments - Susan Done
Resubmission - Version 3
8 Jun 2010 Submitted Manuscript version 3
22 Jun 2010 Author responded Author comments - Susan Done
Resubmission - Version 4
22 Jun 2010 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
21 Jul 2010 Author responded Author comments - Susan Done
Resubmission - Version 8
21 Jul 2010 Submitted Manuscript version 8
Publishing
22 Jul 2010 Editorially accepted
22 Jul 2010 Article published 10.1186/1471-2407-10-390

You can find further information about peer review here.

Back to article page